Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Central Europe and the Baltics

Central Europe and the Baltics: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 12.4% in 2021. ▼ Falling

Latest (2021)
12.4%
Change on year
down 0.5%
Rank
39th
of 47 groups
All-time high
17.4%
in 2000
All-time low
12.4%
in 2019
Years of data
22
2000–2021

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Central Europe and the Baltics, 2000–2021

0510152000201020212000: 17.4 %2001: 16.9 %2002: 16.6 %2003: 16.3 %2004: 15.9 %2005: 15.7 %2006: 15.4 %2007: 15.1 %2008: 14.7 %2009: 14.5 %2010: 14.1 %2011: 13.8 %2012: 13.7 %2013: 13.4 %2014: 13.2 %2015: 13.3 %2016: 12.9 %2017: 12.8 %2018: 12.8 %2019: 12.4 %2020: 12.4 %2021: 12.4 %

Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.

Analysis

In 2021, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Central Europe and the Baltics stood at 12.4%.

The figure is down 0.5% on the previous year and down 10.2% over ten years.

Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Central Europe and the Baltics peaked at 17.4% in 2000 and was at its lowest, 12.4%, in 2019.

That places Central Europe and the Baltics 39th out of 47 groups with data for 2021, putting it in the bottom quarter.

The long-run direction has been consistently falling across the 22 years of available data.

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Central Europe and the Baltics, year by year

Annual values for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) in Central Europe and the Baltics, 2000 to 2021.
Year % Change
2000 17.4%
2001 16.9% -2.7%
2002 16.6% -1.7%
2003 16.3% -1.8%
2004 15.9% -2.6%
2005 15.7% -1.7%
2006 15.4% -1.7%
2007 15.1% -1.9%
2008 14.7% -2.7%
2009 14.5% -1.2%
2010 14.1% -2.6%
2011 13.8% -2.4%
2012 13.7% -0.9%
2013 13.4% -1.8%
2014 13.2% -1.6%
2015 13.3% +0.6%
2016 12.9% -3.1%
2017 12.8% -0.1%
2018 12.8% -0.5%
2019 12.4% -3.3%
2020 12.4% +0.6%
2021 12.4% -0.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 15.9% 14.5% 17.4% 10
2010s 13.2% 12.4% 14.1% 10
2020s 12.4% 12.4% 12.4% 2

Countries ranked near Central Europe and the Baltics

  1. 36 Angola 22.7% compare
  2. 37 Sudan 22.4% compare
  3. 38 Mozambique 22.3% compare
  4. 39 Namibia 22.1% compare
  5. 40 Niger 21.6% compare
  6. 40 Zambia 21.6% compare
  7. 42 Egypt 21.4% compare
  8. 42 Turkmenistan 21.4% compare

See the full ranking of 232 places →

More health data for Central Europe and the Baltics

All data for Central Europe and the Baltics →

Frequently asked questions

What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Central Europe and the Baltics?
Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Central Europe and the Baltics was 12.4% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Central Europe and the Baltics?
The highest recorded value was 17.4% in 2000.
What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Central Europe and the Baltics?
The lowest recorded value was 12.4% in 2019.
How does Central Europe and the Baltics rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Central Europe and the Baltics ranks 39th out of 47 groups with data for 2021.
Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Central Europe and the Baltics?
Over the last ten years it is down 10.2%. The long-run trend across the full record is falling.
Where does this Central Europe and the Baltics data come from?
The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Central Europe and the Baltics. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 17 September 2026, from https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/central-europe-and-the-baltics/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-female-percent/central-europe-and-the-baltics/">Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Central Europe and the Baltics</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).